Market Trends of Global ELISA Analyzer Industry
This section covers the major market trends shaping the ELISA Analyzer Market according to our research experts:
Automated ELISA Analyzers are Expected to Witness High Growth Over the Forecast Period
Automated ELISA analyzers have various advantages over semi-automated ELISA analyzers. Thus, this makes them a preferred choice in testing laboratories. For instance, automation provides the possibility of a walk-away workflow that saves time. Furthermore, other benefits of automated ELISA analyzers include increased accuracy in results, cost efficiency, and fast turnaround times.
In addition, automation also provides an increase in flexibility. For instance, with the help of software and robotic component, automated analyzers can turn into a flexible workstation that can easily adapt to the required application. Hence, these benefits lead to a surge in their demand thereby driving the growth of the segment.
Other factors such as the high cost of automated ELISA analyzers are another factor that leads to a surge in revenues generated in the segment. In addition, key companies operating in the market are adopting strategies to provide advanced automated ELISA analyzers. This in turn leads to a surge in demand for automated analyzers thereby driving the growth of the segment. For instance, in August 2021, Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH merged with Gold Standard Diagnostics Inc. Furthermore, Gold Standard Diagnostics provides its ELISA automated analyzers through Novatec Immundiagnostica GmbH. Hence these factors drive the growth of the segment.
North America is Expected to Dominate the ELISA Analyzer Market
North America is expected to dominate the market. This is due to the surge in the prevalence of infectious diseases such as HIV, Lyme disease, hepatitis C and others that require ELISA testing. For instance, FAIR Health released a study in August 2022. The study claimed a substantial rise in Lyme disease diagnoses between 2007 to 2021 in both rural and urban areas in the United States. Furthermore, the results of the study indicated that private insurance claims associated with Lyme disease diagnoses increased by 357% in rural areas and 65% in urban areas.
Similarly, according to preliminary data reported by the Centers for Disease Control and Prevention (CDC), there were 101,590 cases of syphilis in 2017 in the United States which reached 171,074 cases of syphilis in 2021. Thus, the surge in prevalence of infectious diseases in the region leads to a surge in demand for ELISA analyzers thereby driving the growth of the market.
Furthermore, factors such as the presence of key players in the region lead to the easy availability of advanced automated ELISA analyzers which in turn contributes to the growth of the market. Some of the key players operating in the region include PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Eurofins Scientific (Eurofins Abraxis), Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), and Awareness Technology, Inc. Therefore, owing to the previously mentioned factors the growth of the market studied is anticipated in the North America Region.
